Exponent

EXPO · NASDAQ

$72.55+$0.30 (+0.42%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $72.25

EXPO analyst rating

BuyConsensus of 3 analysts over the last 12 months. 67% rate it a buy.

Strong buy0
Buy2
Hold1
Underperform0
Sell0

12-month price target · 5 analysts

Average $82.62 (+13.9% upside)

Low: $72.72
Now: $72.55
High: $94.50

Upgrades and downgrades

The latest rating actions, newest first

EXPO analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
UBS	Jul 31, 2026	Maintains	Neutral	$75.00 → $72.00	51%
JP Morgan	Jul 31, 2026	Maintains	Overweight	$80.00 → $90.00	27%
JP Morgan	May 15, 2026	Maintains	Overweight	$95.00 → $80.00	27%
UBS	May 1, 2026	Maintains	Neutral	$85.00 → $75.00	51%
JP Morgan	Mar 26, 2026	Maintains	Overweight	$100.00 → $95.00	27%
JP Morgan	Jan 26, 2026	Initiates	Overweight	$100.00	27%
UBS	Dec 15, 2025	Maintains	Neutral	$76.00 → $81.00	51%
William Blair	Nov 17, 2025	Upgrade	Market Perform → Outperform	—	80%

The case for and against

Updated Nov 24, 2024

Bull case

Exponent Inc has demonstrated solid financial performance, with a year-over-year increase in net revenues of 1% to $113.9 million and a notable 14% growth in earnings per share (EPS) to $0.57. The utilization rate rose to 75% in the latest quarter, up from 69% a year ago, indicating improved efficiency and productivity within the company's consulting segments, which are primarily driven by engineering services. Additionally, the projected EBITDA margin range for the third quarter increased significantly to between 26.75% and 27.5%, surpassing analyst expectations and reflecting enhanced profitability, which supports a positive financial outlook for the company.

Bear case

Exponent Inc's recent profitability figures fell short of market expectations, with an EBITDA of $30.5 million versus the consensus of $31.7 million, which reflects a margin compression of 80 basis points year-over-year due to post-pandemic expense normalization and reduced utilization rates. The company's forward-looking guidance indicates a bleak outlook, forecasting flat to low-single digit revenue growth for both the first quarter of 2024 and for the full year, significantly below consensus estimates which anticipate a modest increase. Additionally, a projected decline in average headcount and persistently weaker demand, particularly in the Consumer Electronics sector, further supports concerns regarding Exponent's revenue trajectory and overall financial stability.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.